Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District,…
